Drug profile · INN
dexamfetamine
ASPEN PHARMACARE AUSTRALIA PTY LTD
dexamfetamine (ASPEN PHARMACARE AUSTRALIA PTY LTD) is a dopamine transporter releasing agent. Associated with Lacuna Pharma Pty Ltd.
Drug details — dexamfetamine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 28
- Data quality
- 0.81
Quick answer
dexamfetamine (ASPEN PHARMACARE AUSTRALIA PTY LTD) is a dopamine transporter releasing agent. Associated with Lacuna Pharma Pty Ltd.
Key facts
Mechanism of action
Dopamine transporter releasing agent
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
- 6520-9970-08
- Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg
- Lisdexamfetamine Dimesylate (LDX)
- Lisdexamfetamine dimesylate
- SPD489 (Lisdexamfetamine dimesylate)
- SPD489 (Lisdexamfetamine dimesylate)
- SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
- Vyvanse (lisdexamfetamine dimesylate)
Related & competitor drugs
Frequently asked questions
What is dexamfetamine?
dexamfetamine (ASPEN PHARMACARE AUSTRALIA PTY LTD) is a dopamine transporter releasing agent. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for dexamfetamine?
ASPEN PHARMACARE AUSTRALIA PTY LTD is a marketed brand name for dexamfetamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.